Short Interest in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Expands By 63.9%

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a large increase in short interest in August. As of August 14th, there was short interest totaling 18,771 shares, an increase of 63.9% from the July 30th total of 11,453 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily volume of 3,579 shares, the days-to-cover ratio is presently 5.2 days.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC increased its holdings in F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the period. Hunter Associates Investment Management LLC owned approximately 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.

F/m Emerald Life Sciences Innovation ETF Price Performance

F/m Emerald Life Sciences Innovation ETF stock traded down $0.09 during midday trading on Tuesday, reaching $45.70. 2,273 shares of the stock traded hands, compared to its average volume of 4,633. The stock’s fifty day moving average is $46.14 and its 200-day moving average is $40.19. F/m Emerald Life Sciences Innovation ETF has a 12 month low of $27.67 and a 12 month high of $48.78.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.